Daniel C. Martin
Daniel C. Martin is Chief Commercial Officer of Deciphera Pharmaceuticals, Inc.
In the past Mr. Martin occupied the position of Vice President-Marketing & Market Access at Heron Therapeutics, Inc.
Mr. Martin received an undergraduate degree from the University of Virginia and an MBA from The Wharton School of the University of Pennsylvania.
Transactions
Date
Transaction
Value
| 02/16/2023 | 1,159 | Disposition at $15.1 per share. | 17,501 |
| 02/15/2023 | 11,151 | Award at $0 per share. | 0 |
| 01/17/2023 | 1,603 | Disposition at $21.24 per share. | 34,048 |
| 06/16/2022 | 1,311 | Disposition at $10.75 per share. | 14,094 |
| 02/16/2022 | 1,146 | Disposition at $9.05 per share. | 10,372 |
| 01/18/2022 | 13,667 | Award at $0 per share. | 0 |
| 12/15/2021 | 8,300 | Award at $0 per share. | 0 |
| 01/22/2020 | 26,999 | Disposition at $67.18 per share. | 1,813,793 |
| 01/22/2020 | 26,999 | Derivative/Non-derivative trans. at $36.1 per share. | 974,663 |
| 09/19/2019 | 3,000 | Disposition at $35.56 per share. | 106,680 |
| 09/18/2018 | 20,000 | Award at $0 per share. | 0 |
